Home › Compare › OSGSY vs ABBV
OSGSY yields 1.65% · ABBV yields 3.06%● Live data
📍 OSGSY pulled ahead of the other in Year 5
Combined, OSGSY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OSGSY + ABBV for your $10,000?
Osaka Gas Co., Ltd. provides gas, electricity, and other energy products and services in Japan and internationally. It operates through four segments: Domestic Energy/Gas, Domestic Energy/Electricity, International Energy, and Life & Business Solutions. The Domestic Energy/Gas segment manufactures, supplies, sells, and maintains gas; engages in the gas piping works, call center operation, temporary staffing, various research and consulting, engineering and construction, leasing, installment payments assistance, energy service, and other activities, as well as insurance agency business; operates and maintains LNG terminals and power plants; supplies heat; and generates, sells, and maintains electricity. This segment also sells liquefied nitrogen, liquefied oxygen, and liquefied argon; gas appliances, and housing equipment and appliances; LNG and LPG; and others. The Domestic Energy/Electricity segment supplies electric power. It generates and sells electricity from natural gas, wind, biomass, and solar resources. The International Energy segment engages in the LNG transport; development and investment of petroleum and natural gas; investment relating to energy supply business; and energy supply business. The Life & Business Solutions segment manufactures and sells fine materials, carbon material products, activated carbon, wood protective coatings, absorbent functional materials, and resin additives; develops, leases, manages, and sells real estate properties; develops software products; and provides computer-based data processing services. This segment is also involved in the operation, management, and maintenance of buildings and facilities, and others. The company was founded in 1897 and is headquartered in Osaka, Japan.
Full OSGSY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.